A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear

Journal of Psychiatric Research

Volumn 41, Issue 6, 2007, Pages 466-471

  Guastella, Adam J ^a   Dadds, Mark R ^a   Lovibond, Peter F ^a   Mitchell, Philip ^a   Richardson, Rick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety disorders; d Cycloserine; Exposure therapy; Extinction; Generalisation; Phobia

Indexed keywords

CYCLOSERINE; PLACEBO;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; EVALUATION; EXPOSURE; EXPOSURE THERAPY; FEMALE; FOLLOW UP; HUMAN; LEARNING; MALE; OUTCOME ASSESSMENT; PHOBIA; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SPIDER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOSERINE; DRUG ADMINISTRATION SCHEDULE; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; N-METHYLASPARTATE; PHOBIC DISORDERS; PHOTIC STIMULATION; SPIDERS;

EID: 33846883293     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.05.006     Document Type: Article

References (14)

1. Borkovec T.D., and Craighead W.E. The comparison of two methods of assessing fear and avoidance behavior. Behaviour Research and Therapy 9 3 (1971) 285-291
2. D'Souza D.C., Gil R., Cassello K., Morrissey K., Abi-Saab D., White J., et al. IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry 47 (2000) 450-462
3. Hardman J., and Limbird L. Goodman and Gilman's pharmacological basis of therapeutics. 10th ed. (2001), McGraw Hill, New York
4. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., et al. Augmentation of exposure therapy for social anxiety disorder with d-cycloserine. Archives of General Psychiatry 63 (2006) 298-304
5. Klorman R., Hastings J.E., Weerts T.C., Melamed B.G., and Lang P.J. Psychometric description of some specific-fear questionnaires. Behavior Therapy 5 (1974) 401-409
6. Mineka S., Mystkowski J.L., Hladek D., and Rodriguez B.I. The effects of changing contexts on return of fear following exposure therapy for spider fear. Journal of Consulting and Clinical Psychology 67 (1999) 599-604
7. Mystkowski J.L., Mineka S., Vernon L.L., and Zinbarg R.E. Changes in caffeine states enhance return of fear in spider phobia. Journal of Consulting and Clinical Psychology 71 (2003) 243-250
8. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 61 (2004) 1136-1144
9. Richardson R., Ledgerwood L., and Cranney J. Facilitation of fear extinction by d-cycloserine: theoretical and clinical implications. Learning and Memory 11 (2004) 510-516
10. Rodriguez B.I., Craske M.G., Mineka S., and Hladek D. Context-specificity of relapse: effects of therapist and environmental context on return of fear. Behaviour Research and Therapy 37 (1999) 845-862
11. Rowe M.K., and Craske M.G. Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear. Behaviour Research and Therapy 36 (1998) 701-717
12. Rowe M.K., and Craske M.G. Effects of varied-stimulus exposure training on fear reduction and return of fear. Behaviour Research and Therapy 36 (1998) 719-734
13. van Berckel B.N., Lipsch C., Timp S., Gispen-de Wied C., Wynne H., van Ree J.M., et al. Behavioral and neuroendocrine effects of the partial NMDA agonist d-cycloserine in healthy subjects. Neuropsychopharmacology 16 (1997) 317-324
14. Walker D.L., Ressler K.J., Lu K.T., and Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience 22 (2002) 2343-2351